Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8161869rdf:typepubmed:Citationlld:pubmed
pubmed-article:8161869lifeskim:mentionsumls-concept:C1304649lld:lifeskim
pubmed-article:8161869lifeskim:mentionsumls-concept:C1516634lld:lifeskim
pubmed-article:8161869lifeskim:mentionsumls-concept:C1261322lld:lifeskim
pubmed-article:8161869lifeskim:mentionsumls-concept:C0030068lld:lifeskim
pubmed-article:8161869pubmed:issue1lld:pubmed
pubmed-article:8161869pubmed:dateCreated1994-5-24lld:pubmed
pubmed-article:8161869pubmed:abstractTextTwelve consecutive patients undergoing elective cardiac surgery were perfused with the Cobe Optima hollow fibre oxygenator. Gas transfer characteristics and blood handling were studied. The device had a maximum oxygen transfer of 315 ml/minute. The average shunt fraction was 4.5%, and was not influenced by blood-flow rate. Mean platelet count declined slightly to 91% of the baseline at the end of the study period. Haemolysis was evaluated by monitoring serum-free haemoglobin, serum haptoglobin and serum haemopexin. The evolution was as follows: free haemoglobin increased from 14 +/- 5 mg/100 ml to 85 +/- 0.8/100 ml (p = 0.01) at the end of bypass; haptoglobin decreased from 1.33 +/- 0.90 g/l to 0.89 +/- 0.15 g/l (p = 0.01); and haemopexin decreased from 0.84 +/- 0.13 g/l to 0.74 +/- 0.15 g/l (p = nonsignificant). In all patients the residual capacity of serum haptoglobin to protect against haemolysis was satisfactory. All patients had an uneventful postoperative course.lld:pubmed
pubmed-article:8161869pubmed:languageenglld:pubmed
pubmed-article:8161869pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8161869pubmed:citationSubsetIMlld:pubmed
pubmed-article:8161869pubmed:statusMEDLINElld:pubmed
pubmed-article:8161869pubmed:monthJanlld:pubmed
pubmed-article:8161869pubmed:issn0267-6591lld:pubmed
pubmed-article:8161869pubmed:authorpubmed-author:Van NootenGGlld:pubmed
pubmed-article:8161869pubmed:authorpubmed-author:DelangheJJlld:pubmed
pubmed-article:8161869pubmed:authorpubmed-author:De SomerFFlld:pubmed
pubmed-article:8161869pubmed:authorpubmed-author:CaesFFlld:pubmed
pubmed-article:8161869pubmed:authorpubmed-author:De SmetDDlld:pubmed
pubmed-article:8161869pubmed:authorpubmed-author:VanackereMMlld:pubmed
pubmed-article:8161869pubmed:issnTypePrintlld:pubmed
pubmed-article:8161869pubmed:volume9lld:pubmed
pubmed-article:8161869pubmed:ownerNLMlld:pubmed
pubmed-article:8161869pubmed:authorsCompleteYlld:pubmed
pubmed-article:8161869pubmed:pagination57-64lld:pubmed
pubmed-article:8161869pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:8161869pubmed:meshHeadingpubmed-meshheading:8161869-...lld:pubmed
pubmed-article:8161869pubmed:meshHeadingpubmed-meshheading:8161869-...lld:pubmed
pubmed-article:8161869pubmed:meshHeadingpubmed-meshheading:8161869-...lld:pubmed
pubmed-article:8161869pubmed:meshHeadingpubmed-meshheading:8161869-...lld:pubmed
pubmed-article:8161869pubmed:meshHeadingpubmed-meshheading:8161869-...lld:pubmed
pubmed-article:8161869pubmed:meshHeadingpubmed-meshheading:8161869-...lld:pubmed
pubmed-article:8161869pubmed:meshHeadingpubmed-meshheading:8161869-...lld:pubmed
pubmed-article:8161869pubmed:meshHeadingpubmed-meshheading:8161869-...lld:pubmed
pubmed-article:8161869pubmed:meshHeadingpubmed-meshheading:8161869-...lld:pubmed
pubmed-article:8161869pubmed:meshHeadingpubmed-meshheading:8161869-...lld:pubmed
pubmed-article:8161869pubmed:meshHeadingpubmed-meshheading:8161869-...lld:pubmed
pubmed-article:8161869pubmed:year1994lld:pubmed
pubmed-article:8161869pubmed:articleTitleClinical evaluation of a new hollow fibre membrane oxygenator.lld:pubmed
pubmed-article:8161869pubmed:affiliationDepartment of Perfusion, University Hospital Gent, Belgium.lld:pubmed
pubmed-article:8161869pubmed:publicationTypeJournal Articlelld:pubmed